ENSC
Ensysce Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.46
+3.57%Margins
Gross margin
100.0%
EBITDA margin
-1083.3%
EBIT margin
-1087.5%
Net margin
-1084.2%
FCF margin
-771.2%
1614.9%
Return on equity
-426.9%
Return on assets
2164.9%
Return on invested capital
0.45x
Asset turnover
-$8.9M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026